Breaking News: Large Study Shows Measuring Medication Risk with MedWise® Can Help Reduce Premature Death
Click to learn what these findings mean for medication safety and practice

For Health Plans

The problem: Preventable Medication-Related Problems

The Tabula Rasa HealthCare (TRHC) solution: Clinical Intelligence for Pharmacy and Personalized Medication Management

Health plans and other at-risk healthcare and provider organizations need a way to understand which members are at highest risk of costly medication-related problems, like adverse drug events (ADE), falls, and hospitalizations. Partner with TRHC to identify medication-related risks and then intervene with high-risk members so you can improve adherence and therapeutic outcomes and reduce unnecessary medical and pharmacy expenditures.

TRHC is disrupting the fields of medication adherence and safety. For more than 30 years, traditional medication software systems have offered clinicians a binary view of drug-to-drug interactions, presenting an assessment of one single drug against one single drug. These legacy systems are (arguably*) adequate to assess the safety of a medication regimen consisting of only one or two medications. However, for the elderly and chronically ill, a medication profile of just a few drugs often leaves these patients at high risk of an ADE. The average Medicare patient typically takes ten different medications a day, and current technologies are inadequate to optimize safety and minimize risk.

What we do

TRHC leverages technology to improve health care and reduce costs. TRHC’s Medication Risk Mitigation (MRM) technology delivers a simultaneous, multi-drug review which identifies medication-related risks across a variety of pharmacokinetic and pharmacodynamic safety factors, and presents meaningful opportunities to mitigate those risks. TRHC partners with health plans and provider groups in comprehensive medication therapy management (MTM) and transitions of care (TOC) programs to identify and substantially mitigate the risk associated with ADEs.

The TRHC model (shown left) includes medication risk stratification and assessment – which includes medication risk scoring, clinical interventions, and ongoing support. TRHC uses real-time pharmacy claims data to identify medication-related risks, utilizing pharmacodynamic and pharmacokinetic principles to determine risk and probability of an ADE.

TRHC’s MTM programs offer a comprehensive approach to patient and population health. Our team of adherence-founded pharmacists solely focus on medication reviews and clinical interventions to improve health, wellness, and the management of chronic health conditions. With TRHC’s quality improvement programs, medication adherence modules can be custom selected to target desired goals. Expert clinical staff will work with the patient and their provider to understand the individual needs of the patient, increase medication adherence, and reach the Star improvement goals of the plan.

MTM services can now be reinforced by MedWise® Predictive MTM, our proprietary, science-based medication decision support software. MedWise Predictive MTM elevates the quality of Comprehensive Medication Reviews and adherence interventions by identifying and presenting opportunities to mitigate risk for adverse drug events. This model transforms MTM and adherence programs into innovative solutions by helping to prevent hospitalizations and emergency room visits for patients at risk for adverse drug events. Total cost of care reductions are realized within the same plan year.

* Existing systems even miss the one-drug-to-one-drug interactions that TRHC identifies.